This narrative review examines how stress-induced IL-6 upregulation affects children with juvenile idiopathic arthritis, pediatric systemic lupus erythematosus, and inflammatory bowel disease. The analysis draws on findings from animal models, knockout studies, and pediatric inflammatory disorder models rather than a single clinical trial.
The evidence indicates that this biological pathway can impair skeletal growth, increase bone fragility, and disrupt the GH/IGF-1 axis functioning. It also promotes bone marrow adiposity and inhibits the proliferation and maturation of growth plate chondrocytes. Additionally, muscle health may be impaired under these conditions. These outcomes collectively demonstrate that stress triggers IL-6 in these contexts.
Because the study relies on models and reviews rather than direct patient data, the findings are not practice-changing on their own. However, the main reason to be careful is the identified need for integrative therapeutic strategies that target inflammation and redox imbalance. Readers should understand that while the link between stress and these physical changes is supported by these specific models, more direct evidence in children is needed to confirm the full scope of these risks.
